ABBV

Abbvie

$217.49

Closing price as of Mar 31, 2026

9 superinvestors own ABBV

Based on latest 13F filings — data is 45–90 days delayed

Investor	Fund	Weight	Shares	Value	Quarter	Activity
Torray Funds	Torray Investment Partners	3.03%	92,687	$21.2M	2025Q4	New
David Katz	Matrix Asset Advisors	0.79%	38,285	$8.7M	2025Q4	Reduced
Mairs & Power	Mairs & Power Growth Fund	0.10%	46,456	$10.6M	2025Q4	Reduced
Kenneth Fisher	Fisher Asset Management	0.05%	628,338	$143.6M	2025Q4	Added
Jensen Investment Management	Jensen Investment Management	0.04%	11,144	$2.5M	2025Q4	Reduced
Thomas Russo	Gardner Russo & Quinn	0.03%	12,410	$2.8M	2025Q4	New
Kopernik Global Investors	Kopernik Global Investors	0.01%	4,600	$84K	2025Q4	Added
Bill Nygren	Oakmark Select Fund – Harris Associates	0.00%	2,682	$613K	2025Q4	Reduced
Dodge & Cox	Dodge & Cox	0.00%	10,393	$2.4M	2025Q4	Reduced

Open-market purchases (P) and sales (S) from SEC Form 4 filings · last 12 months

No open-market insider trades in the last 12 months.

Form 4 filings for option exercises and other transaction types are excluded.

STOCK Act disclosures · last 12 months

Congressional trade data coming soon.

We are sourcing STOCK Act disclosures and will display them here shortly.

What Is SEC Form 4?

Understand the insider trade filings behind ABBV activity.

What Is a 13F Filing?

How superinvestors disclose their quarterly holdings.

Insider Cluster Buying

Why multiple insiders buying together is a strong signal.

Superinvestor Consensus

The most widely held stocks across all tracked institutions.